close 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

LLY

1,008.91

-3.56%↓

JNJ

245.26

-2.05%↓

ABBV

233.8

+0.06%↑

NVS

162.28

-2.9%↓

MRK

119.83

-2.59%↓

LLY

1,008.91

-3.56%↓

JNJ

245.26

-2.05%↓

ABBV

233.8

+0.06%↑

NVS

162.28

-2.9%↓

MRK

119.83

-2.59%↓

LLY

1,008.91

-3.56%↓

JNJ

245.26

-2.05%↓

ABBV

233.8

+0.06%↑

NVS

162.28

-2.9%↓

MRK

119.83

-2.59%↓

LLY

1,008.91

-3.56%↓

JNJ

245.26

-2.05%↓

ABBV

233.8

+0.06%↑

NVS

162.28

-2.9%↓

MRK

119.83

-2.59%↓

LLY

1,008.91

-3.56%↓

JNJ

245.26

-2.05%↓

ABBV

233.8

+0.06%↑

NVS

162.28

-2.9%↓

MRK

119.83

-2.59%↓

Strona główna・Stock List・VIRIDIAN THERAPEUTICS INC
Search

VIRIDIAN THERAPEUTICS INC

Open

SectorHealthcare

28.85 0.31

Strong Buy

Price update 3 mar 2026, 14:36 UTC

BuySell

Overview

Share price change

24h

Current

Min

28.68

Max

30.43

Key metrics

By Trading Economics

Income

66M

-35M

Sales

70M

71M

Profit margin

-49.028

Employees

143

EBITDA

66M

-34M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+41.93% upside

Dividends

By Dow Jones

Next Earnings

5 maj 2026

Market Stats

By TradingEconomics

Market Cap

524M

2.7B

Previous open

28.54

Previous close

28.85

News Sentiment

By Acuity

33%

67%

74 / 352 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

12 / 13.14 Support & Resistance

VIRIDIAN THERAPEUTICS INC Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

2 mar 2026, 23:41 UTC

Market Talk
Major News Events

Nikkei May Decline on Concerns About Energy Prices -- Market Talk

DJ

Read

2 mar 2026, 23:37 UTC

Market Talk
Major News Events

Gold Edges Higher Amid Middle East Conflict -- Market Talk

DJ

Read

2 mar 2026, 23:26 UTC

Major News Events

How the Iran Conflict Could Pressure Consumer Staples Companies -- Barrons.com

DJ

Read

2 mar 2026, 22:41 UTC

Market Talk

Australian Reits Wait on Recovery in Trading Multiples -- Market Talk

DJ

Read

2 mar 2026, 22:32 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Read

2 mar 2026, 22:32 UTC

Market Talk

RBA Cautious About Potential for Energy Supply Shocks -- Market Talk

DJ

Read

2 mar 2026, 22:21 UTC

Market Talk

Port of Tauranga's Upgraded Profit View Still Looks Conservative -- Market Talk

DJ

Read

2 mar 2026, 22:11 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Read

2 mar 2026, 22:11 UTC

Market Talk

Don't Lose Sight of Bigger Picture With Summerset -- Market Talk

DJ

Read

2 mar 2026, 22:10 UTC

Acquisitions, Mergers, Takeovers

IAC Is Near Deal to Sell Care.com to Private-Equity Firm -- WSJ

DJ

Read

2 mar 2026, 22:06 UTC

Market Talk

Channel Infrastructure's Dividend Positively Surprises -- Market Talk

DJ

Read

2 mar 2026, 22:00 UTC

Market Talk
Earnings

Global Forex and Fixed Income Roundup: Market Talk

DJ

Read

2 mar 2026, 22:00 UTC

Market Talk
Earnings

Fashion Retailer Hallenstein Glasson Still a Smart Buy -- Market Talk

DJ

Read

2 mar 2026, 21:50 UTC

Market Talk
Major News Events

Energy & Utilities Roundup: Market Talk

DJ

Read

2 mar 2026, 21:50 UTC

Market Talk
Major News Events

Basic Materials Roundup: Market Talk

DJ

Read

2 mar 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

DJ

Read

2 mar 2026, 21:35 UTC

Acquisitions, Mergers, Takeovers

AT&T Expects Net Debt-To-Adjusted Ebitda Ratio Will Rise to About 3.2x Following Deal With EchoStar and Decline to About 3x by End of 2026

DJ

Read

2 mar 2026, 21:34 UTC

Acquisitions, Mergers, Takeovers

AT&T Remains on Track to Achieve Its 2026 and Multi-Yr Fincl Guidance

DJ

Read

2 mar 2026, 21:30 UTC

Acquisitions, Mergers, Takeovers

Update: AES to Be Taken Private in $33 Billion Deal. Why It's the S&P 500's Worst Stock Today. -- Barrons.com

DJ

Read

2 mar 2026, 21:17 UTC

Major News Events

Bank, Brokerage Stocks Recover Lost Ground After Last Week's Selloff -- Despite Iran Conflict -- Barrons.com

DJ

Read

2 mar 2026, 20:44 UTC

Earnings

Berkshire Stock Falls 5% as Earnings, Abel Letter Fail to Excite Investors -- Barrons.com

DJ

Read

2 mar 2026, 20:43 UTC

Market Talk
Major News Events

Treasury Yields Fall, Dollar Strengthens After Attack on Iran -- Market Talk

DJ

Read

2 mar 2026, 20:28 UTC

Earnings

Strategy Stock Rises. The World's Largest Bitcoin Holder Doubles Down on Its Crypto Bet. -- Barrons.com

DJ

Read

2 mar 2026, 20:25 UTC

Market Talk
Major News Events

U.S. Natural Gas Futures Post Moderate Gains -- Market Talk

DJ

Read

2 mar 2026, 20:24 UTC

Earnings

Berkshire Stock Falls 5% as Earnings, Abel Letter Fail to Excite Investors -- Barrons.com

DJ

Read

2 mar 2026, 20:14 UTC

Acquisitions, Mergers, Takeovers

Update: AES to Be Taken Private in $33 Billion Deal. Why It's the S&P 500's Worst Stock Today. -- Barrons.com

DJ

Read

2 mar 2026, 20:12 UTC

Major News Events

Palantir Rises on Mideast Conflict. Why It's Moving Like a Defense Stock. -- Barrons.com

DJ

Read

2 mar 2026, 20:08 UTC

Market Talk
Major News Events

Global Forex and Fixed Income Roundup: Market Talk

DJ

Read

2 mar 2026, 20:08 UTC

Market Talk
Major News Events

Higher Oil Prices Could Boost Capex in Canada Energy Patch -- Market Talk

DJ

Read

2 mar 2026, 20:05 UTC

Market Talk
Major News Events

Oil Rises On U.S.-Middle East Conflict, But Settles Off Highs -- Market Talk

DJ

Read

Peer Comparison

Price change

VIRIDIAN THERAPEUTICS INC Forecast

Price Target

By TipRanks

41.93% upside

12 Months Forecast

Average 41.7 USD  41.93%

High 50 USD

Low 29 USD

Based on 12 Wall Street analysts offering 12 month price targets forVIRIDIAN THERAPEUTICS INC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

12 ratings

11

Buy

1

Hold

0

Sell

Based on 12 analysts giving stock ratings to VIRIDIAN THERAPEUTICS INC - Dist in the past 3 months.

Technical Score

By Trading Central

12 / 13.14Support & Resistance

Short Term

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Bearish Evidence

All events are bearish.

Long Term

Strong Bearish Evidence

All events are bearish.

Sentiment

By Acuity

74 / 352 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

1,008.91

↓-3.56%

JNJ

Johnson and Johnson

245.26

↓-2.05%

ABBV

AbbVie Inc

233.8

↑ +0.06%

NVS

Novartis AG

162.28

↓-2.9%

MRK

Merck & Co Inc.

119.83

↓-2.59%
help-icon Live chat